Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0028754 (obesity)
 124,988 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The purpose of this study was to examine the growth status and prevalence of underweight, overweight, and obesity in Hopi children. Subjects were 263 (117 males, 146 females) Hopi children 6-12 years of age. Stature and mass were measured and the body mass index (BMI) was calculated. Body size variables were plotted relative to age- and sex-specific reference data and the prevalence rates for underweight, overweight, and obesity were estimated using the BMI as the criterion. Age-specific sex differences were compared using independent samples t-tests. In both sexes, mean age-specific stature appeared to be relatively stable around the 50th percentile of reference values. Mean age-specific mass appeared to be relatively stable between the 50th and 90th percentiles of the reference values, while the mean BMI tended to fluctuate about the 85th percentile. Approximately 23% of Hopi children were classified as overweight and an additional 24% were classified as obese. Only two subjects were categorized as underweight. The results are consistent with other reports that childhood obesity is a serious public health concern among Native Americans. Further study is warranted to examine the causes of the high prevalence rates of pediatric obesity among Native Americans and the effectiveness of prevention and intervention programs.
 ...
PMID:Growth status and obesity of Hopi children. 1459 65

To delineate the roles of the lactogens and GH in the control of perinatal and postnatal growth, fat deposition, insulin production, and insulin action, we generated a novel mouse model that combines resistance to all lactogenic hormones with a severe deficiency of pituitary GH. The model was created by breeding PRL receptor (PRLR)-deficient (knockout) males with GH-deficient (little) females. In contrast to mice with isolated GH or PRLR deficiencies, double-mutant (lactogen-resistant and GH-deficient) mice on d 7 of life had growth failure and hypoglycemia. These findings suggest that lactogens and GH act in concert to facilitate weight gain and glucose homeostasis during the perinatal period. Plasma insulin and IGF-I and IGF-II concentrations were decreased in both GH-deficient and double-mutant neonates but were normal in PRLR-deficient mice. Body weights of the double mutants were reduced markedly during the first 3-4 months of age, and adults had striking reductions in femur length, plasma IGF-I and IGF binding protein-3 concentrations, and femoral bone mineral density. By age 6-12 months, however, the double-mutant mice developed obesity, hyperleptinemia, fasting hyperglycemia, relative hypoinsulinemia, insulin resistance, and glucose intolerance; males were affected to a greater degree than females. The combination of perinatal growth failure and late-onset obesity and insulin resistance suggests that the lactogen-resistant/GH-deficient mouse may serve as a model for the development of the metabolic syndrome.
 ...
PMID:Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. 1538 48

Statins have pleiotrophic effects related to the pathogenesis of atherosclerosis and thrombogenicity of the vessel wall beyond lipid lowering. The aim of the present study was to examine the effect of atorvastatin treatment on the fibrinolytic system in patients with dyslipidemia. The investigation was carried out on 41 dyslipidemic patients (21 males and 20 females) with a mean age of 53.8 years (range, 30-76). The patients were divided into subgroups according to their cholesterol and triglyceride levels as hypercholesterolemic (n = 26) and mixed-type hyperlipidemic (n = 15) and their risk factors for coronary heart disease including age, sex, hypertension, obesity, smoking, and family history. The patients were started on atorvastatin 10 mg/day, and evaluated within 6-12 weeks to assess the changes in fibrinolytic parameters including global fibrinolytic capacity, plasminogen activator inhibitor type-1 and tissue plasminogen activator, and lipids. After successful lipid-lowering therapy, global fibrinolytic capacity (P = 0.003) and tissue plasminogen activator levels (P = 0.04) were found to be increased and plasminogen activator inhibitor type-1 levels (P = 0.02) decreased in dyslipidemic patients. Global fibrinolytic capacity levels increased (P < 0.001) and plasminogen activator inhibitor type-1 levels decreased (P = 0.01) in patients with hypercholesterolemia (n = 26). However, no significant changes were observed in fibrinolytic parameters in patients with mixed-type hyperlipidemia (n = 15). When the patients were separately evaluated according to risk factors, significant beneficial effects on the fibrinolytic system were observed, especially in patients without obesity and hypertension as well as in older patients and males. These findings suggest that atorvastatin treatment has a beneficial effect on the fibrinolytic system in patients with hypercholesterolemia, but not in patients with mixed-type hyperlipidemia. Further studies are needed to show whether higher doses and longer periods of lipid lowering treatment have beneficial effects in patients with mixed type hyperlipidemia and some risk factors.
 ...
PMID:The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients. 1565 73

Acceptance of obese individuals as living kidney donors is controversial related to possible increased risk for surgical complications and concern that obesity may contribute to long-term renal disease. We retrospectively examined 553 consecutive hand-assisted laparoscopic living kidney donations between October 1, 1999 and April 1, 2003. We stratified donors into quartiles by baseline body mass index (BMI) assessing perioperative complications and 6-12 months post-donation metabolic and renal function. Compared to BMI <25 kg/m(2), high BMI donors (> or =35 kg/m(2)) had slightly longer operative times (mean increase 19 min), more overall perioperative complications (mostly minor wound complications), yet the same low rate of major surgical complications (conversion to open and re-operation) and similar length-of-stay (2.3 vs. 2.4 days). At 6-12 months after donation (mean 11 months), renal function and microalbuminuria did not differ with BMI. These results suggest that laparoscopic donor nephrectomy is generally safe in selected obese donors and does not result in a high rate of major perioperative complications. Obese donors have higher baseline cardiovascular risk and warrant risk reduction for long-term health. While early results are encouraging, we advocate careful study of obese donors and do not support their widespread use until longer follow-up is available.
 ...
PMID:Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. 1581 86

Ever since the publication of the first textbook on human growth by Johann Augustin Stoeller in 1729, temporal changes (or secular trends) in growth and pubertal maturation have been observed throughout the world. Data covering the longest time span are often reported from European populations. For example, in Norway and Denmark the age at menarche has fallen rapidly since the 19th century, by up to 12 months per decade. These changes have broadly paralleled increases in adult height in most European countries over the last century, with rates of around 10-30mm per decade. These secular trends are influenced by background ethnic, geographical and socio-economic factors, and clearly nutritional changes have an important role as reflected by positive correlations between age at puberty onset or age at menarche and childhood body size. Changes in height, pubertal maturation, and childhood body size have all also been related to rate of weight gain in infancy, and there is growing evidence to suggest that this early postnatal period may represent an early window of susceptibility to long-term 'programming' of various outcomes in humans. There is debate as to whether the secular trends in pubertal maturation are continuing or have reached their limit. Even where temporal changes are overall clearly significant, they are most marked in the more nutritionally deprived sub-groups. Whether over-nutrition and increasing childhood obesity will continue to lead earlier puberty is uncertain. The confirmation of an estimated advance in the age at menarche of 6-12 months per 100 years will require a long-term perspective on behalf of current investigators, and new consideration of methodological approaches in an age of increasing recognition of children's rights for privacy.
 ...
PMID:Lessons from large population studies on timing and tempo of puberty (secular trends and relation to body size): the European trend. 1675 3

Effective surveillance of trends in paediatric overweight and obesity requires the establishment of valid cutoff values to identify children at risk. In Israel, standard values for childhood BMI-for-age are currently based on growth charts published by the US Centers for Disease Control and Prevention. However, the appropriateness of using US reference values in populations outside the US is questionable, due to inherent differences in ethnicity, culture and socioeconomic status. We recorded data from 9,988 children aged 6-12 selected by random cluster sampling within the framework of school-based health surveys conducted in Israel during the years 1997 and 2000. We constructed population-specific centile BMI-for-age curves valid for Israeli children, and compared these curves to current standard US and international reference values. Curves were constructed using LMS statistical curve smoothing methods. The data set of Israeli schoolchildren produced reference centiles substantially different than those based on US children. Israeli reference values were closer to centile curves published by the International Obesity Task Force. In conclusion, local and national health planners should recognize the intrinsic limitations associated with the use of "standard" reference values in defining paediatric overweight and obesity in dissimilar populations. The results of this large population-based study highlight the need for population-specific BMI-for-age reference values, in order to accurately describe the prevalence of paediatric overweight and obesity.
 ...
PMID:Appropriateness of US and international BMI-for-age reference curves in defining adiposity among Israeli school children. 1702 45

A retrospective study was done in 66 children (0.21% of all admitted children) below the age of 18 years with persistent hypertension diagnosed at the Department of Pediatrics, Faculty of Medicine Siriraj Hospital from Jan 1999 to Dec 2003. Male to female ratio was 1.4:1 with 54.5% aged between 6-12 years old and 9.1% aged less than 1 year. Hypertension was found to be severe (BP more than the 99th percentile for age, sex and height) in 79.1% but most (78.6%) of the patients did not have symptoms related to hypertension. Chronic headaches were found in 10%, hypertensive encephalopathy in 8.6%, epistaxis in 1.4% and visual disturbance in 1.4%. The most common cause of hypertension was renal parenchymal diseases (62.7%) mainly lupus nephritis (26.9%), idiopathic nephrotic syndrome (16.4%) and chronic renal failure (16.4%). Other causes of hypertension included renovascular diseases (7.5%), drug-induced (7.5%), essential (7.5%), tumors (4.5%), coarctation of aorta (3.0%), bronchopulmonary dysplasia (3.0%), and pheochromocytoma (1.5%). Obesity and overweight (body mass index, BMI more than 25) was found in only 10 patients (15.1%). The proportion of children with BMI more than 25 was not different between essential and secondary hypertension (p = 0.15). Left ventricular hypertrophy was noted in 7.5%, hypertensive retinopathy in 3.0%, and hypertensive encephalopathy in 9.0%. One-third of the patients had normal BP within 1 month and another 47.0% had normal BP within 6 months of diagnosis. One-fifth of the patients also needed surgical intervention for specific underlying diseases. The authors suggest that since a large number of children with hypertension have secondary hypertension, intensive investigation and prompt management should be done in all. Obesity and overweight is not reliable in the differentiation between primary and secondary hypertension. Short term outcome of hypertension is good with medications and surgery in selected cases but long term outcome is still unknown.
 ...
PMID:Persistent hypertension in Thai children: etiologies and outcome. 1704 51

Both obesity and prostate cancer are epidemic in Western society. Although initial epidemiologic data appeared conflicting, recent studies, especially large prospective studies published in the past 6-12 months, have clarified the association between obesity and prostate cancer. The aim of this paper is to review the epidemiologic data linking obesity and prostate cancer, with an emphasis on new data published since 2005. A PubMed search was done on the keywords, "prostate cancer" and "obesity." Relevant articles and their references were reviewed for data on the association between obesity and prostate cancer. Recent data suggest that obesity is associated with reduced risk of nonaggressive disease but increased risk of aggressive disease. This may in part be explained by an inherent bias in our ability to detect prostate cancer in obese men (lower prostate-specific antigen values and larger sized prostates making biopsy less accurate for finding an existing cancer). Ultimately, this leads to increased risk of cancer recurrence after primary therapy and increased risk of prostate cancer mortality. The biologic causes of these associations are likely multifactorial, although the lower testosterone levels among obese men appear to be one of the most promising explanations. The association between obesity and prostate cancer is complex. Emerging data suggest a differential effect of obesity by disease aggressiveness: obesity may reduce the risk of nonaggressive disease while it may promote aggressive disease.
 ...
PMID:Obesity and prostate cancer: making sense out of apparently conflicting data. 1747 39

Implementation of a lowenergy diet is recommended for overweight and obesity treatment. However, some patients gain weight after successful body weight reduction achieved at the beginning. This study was aimed to evaluate body weight and body composition changes in subjects with BMI > or = 25 after 1 year of a low-energy diet. The study group consisted of 70 women, aged 47.3, BMI 37.5 kg/m2 and 25 men, aged 42.4, BMI 37.1 kg/m2. 1000 kcal diet was recommended for women and 1500 kcal diet for men. Body weight measurement and body composition assessment by BIA were performed at entry and every 2 months of the study. Subjects were divided in 2 groups: I--patients with body weight reduction achieved after 6 and 12 months of treatment (38 women, 16 men), II--subjects who lost weight in first 6 months and gained weight in the next 6 months (32 women, 9 men). After 1 year treatment averaged body weight reduction in women was 11.9% +/- 8.6, in men 13.9% +/- 8.3. In women from group I body weight decrement was 16.4 +/- 11.2 kg (15 +/- 9%), and in women from group II 7.5 +/- 7.7 kg, (8.1 +/- 6.7%), respectively. Men in group I lost 22 +/- 14.3 kg (16.7 +/- 8.7%), men in group II 8.8 +/- 5.3 kg (9 +/- 5.3%). 10% body weight reduction after 1 year was achieved in 29 women (41.4%) and in 16 men (64%). In group I changes of body weight in 6-12 months were related to body weight decrement in the first 6 months, in group II this correlation was not stated. Effect of treatment achieved in 6-12 months was not related to age. Implementation of a low energy diet resulted in body weight reduction, the goal of treatment--10% body weight decrement, was achieved in 41.4% women and in 64% men.
 ...
PMID:[Effect of a low-energy diet on body weight and body composition after one year treatment]. 1747 57

The prevalence of obesity in Spain is at 15.5% and its cost is at some 2,000 million Euro. The evolutionary response to hunger was to create mechanisms for storing energy using diverse hormones: insulin, leptin, ghrelin, resistin, neuropeptide Y, AgRS, MCH, the carbaminoid system, and so on. These served to maximize ingestion or to create resistance to insulin and leptin. A 'saving' genotype was thus created and registered in our genome, with energy savings and reduced expenditure. But with the availability of more foods without physical effort, this savings genotype is no longer valid, as it gives rise to the metabolic syndrome, with increased cardiovascular risk. Current treatments are rather ineffective; we need to adapt our lifestyles to the conditions for which we were designed. We have set up an Obesity School with a 13-hour program, completed by some 64% of those registered (20% do not attend), with an average weight loss at four months of 5.9 kgs and a reduction of 2.26% in body fat. At 6-12 months from the completion of the course, 60% continue losing (-10 kgs), with only 26.5% re-gaining weight (+4.75 kgs).
 ...
PMID:[Obesity, the price of survival]. 1769 Dec 1


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>